BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6083796)

  • 41. Epinephrine, norepinephrine, dopamine and serotonin: differential effects of acute and chronic stress on regional brain amines.
    Roth KA; Mefford IM; Barchas JD
    Brain Res; 1982 May; 239(2):417-24. PubMed ID: 6178468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
    Guldberg HC; Yates CM
    Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain concentrations of biogenic amines and their metabolites in two types of pyrogen-induced fever in rabbits.
    Gardey-Levassort C; Tanguy O; Lechat P
    J Neurochem; 1977 Jan; 28(1):177-82. PubMed ID: 13153
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of a new eburnamine derivative, RU 24722, on the turnover of monoamines in mouse brain: selective and reversible decrease of noradrenaline.
    Takeda N; Yamatodani A; Watanabe T; Wada H
    Eur J Pharmacol; 1984 Nov; 106(2):357-62. PubMed ID: 6085052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of African trypanosomiasis on brain levels of dopamine, serotonin, 5-hydroxyindoleacetic acid, and homovanillic acid in the rabbit.
    Stibbs HH
    J Neurochem; 1984 Nov; 43(5):1253-6. PubMed ID: 6208325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proceedings: The ontogenesis of cerebral dopamine metabolism in the pig.
    Fry JP; Sharman DF; Stephens DB
    Br J Pharmacol; 1976 Mar; 56(3):372P. PubMed ID: 1260200
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of the effects of the novel antipsychotic agent remoxipride on dopamine and noradrenaline turnover in the rat brain.
    Magnusson O; Fowler CJ
    Pharmacol Toxicol; 1989 Oct; 65(4):295-8. PubMed ID: 2573899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrinsic exercise capacity is related to differential monoaminergic activity in the rat forebrain.
    Rabelo PC; Almeida TF; Guimarães JB; Barcellos LA; Cordeiro LM; Moraes MM; Coimbra CC; Szawka RE; Soares DD
    Brain Res Bull; 2015 Mar; 112():7-13. PubMed ID: 25617713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of D2 receptors and dopamine levels in the thalamus of the rat.
    Young KA; Wilcox RE
    Life Sci; 1991; 48(19):1845-52. PubMed ID: 1645835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria.
    Puglisi-Allegra S; Cabib S; Pascucci T; Ventura R; Cali F; Romano V
    Neuroreport; 2000 Apr; 11(6):1361-4. PubMed ID: 10817622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo neurochemical and anatomical heterogeneity of the dopamine uptake system in the rat caudate putamen.
    Glynn GE; Yamamoto BK
    Brain Res; 1989 Mar; 481(2):235-41. PubMed ID: 2524237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Differential depletion of storage sites for noradrenalin, dopamine and serotonin by oxypertin].
    Hassler R; Bak IJ; Kim JS
    Nervenarzt; 1970 Mar; 41(3):105-18. PubMed ID: 5447883
    [No Abstract]   [Full Text] [Related]  

  • 53. Changes in biogenic amines in rat hippocampus during development and aging.
    Santiago M; Machado A; Reinoso-Suárez F; Cano J
    Life Sci; 1988; 42(24):2503-8. PubMed ID: 2453775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytomegalovirus infection of the developing brain alters catecholamine and indoleamine metabolism.
    O'Kusky JR; Boyes BE; Walker DG; McGeer EG
    Brain Res; 1991 Sep; 559(2):322-30. PubMed ID: 1724407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlative changes of serotonin and catecholamines with pharmacokinetic alterations of imipramine in rat brain.
    Sugita S; Kobayashi A; Suzuki S; Yoshida T; Nakazawa K
    Eur J Pharmacol; 1989 Jun; 165(2-3):191-8. PubMed ID: 2476322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of SM-9018, a potential atypical neuroleptic, on the central monoaminergic system in rats.
    Maruoka Y; Ohno Y; Kato T; Hirose A; Tatsuno T; Nakamura M
    Jpn J Pharmacol; 1993 Aug; 62(4):419-22. PubMed ID: 7901446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of neuropeptide Y on striatal catecholamines.
    Beal MF; Frank RC; Ellison DW; Martin JB
    Neurosci Lett; 1986 Oct; 71(1):118-23. PubMed ID: 2431356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurotoxicological effects of a pyrethroid formulation, fenvalerate in rats.
    Husain R; Gupta A; Khanna VK; Seth PK
    Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):111-4. PubMed ID: 1882120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic neurotransmission in chronic herpes simplex virus brain infection in rabbits.
    Päivärinta MA; Marttila RJ; Rinne JO; Rinne UK
    J Neural Transm Gen Sect; 1993; 93(3):205-12. PubMed ID: 7692884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methamphetamine: toxicity to dopaminergic neurons.
    Seiden LS
    NIDA Res Monogr; 1985; 62():100-16. PubMed ID: 2867472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.